Deutsch
 
Mein Konto  

ANMELDEN & VORTEILE SICHERN

  • Preise & Rabatte einsehen
  • Geschenke sichern
  • Angebote anfragen & online annehmen
JETZT ANMELDEN Noch nicht registriert? Konto hier erstellen!
Vergleich
Ergebnisse

Ergebnisse filtern

Typ
Specific against
Host
Clone
  1. 1(23)
  2. 10(9)
  3. 10C12(4)
  4. 10F.9G2(23)
  5. 116-13.1(10)
  6. 11B11(20)
  7. 12G5(5)
  8. 14-4-4S(10)
  9. 145-2C11(19)
  10. 15(9)
  11. 15-3-1S(4)
  12. 15A7(4)
  13. 16-10A1(19)
  14. 178 (LALAPG)(5)
  15. 17A2(8)
  16. 18B12(7)
  17. 1a3(5)
  18. 1A8(19)
  19. 1D11.1(5)
  20. 1D11.16.8(10)
  21. 1D3(14)
  22. 1F6(9)
  23. 1G9(26)
  24. 1H1(6)
  25. 2(23)
  26. 2.4G2(19)
  27. 20D5(14)
  28. 20H2(5)
  29. 225(4)
  30. 22D1(19)
  31. 24(5)
  32. 29E.2A3(16)
  33. 29F.1A12(19)
  34. 2D5(10)
  35. 2D5-1.9(9)
  36. 2H7(19)
  37. 3(28)
  38. 30-H12(19)
  39. 33D1(40)
  40. 37(9)
  41. 38(5)
  42. 38/42(4)
  43. 384-35(5)
  44. 3E8#(4)
  45. 3G8(15)
  46. 3H10.1(19)
  47. 3H3(19)
  48. 4(5)
  49. 43(9)
  50. 480(14)
  51. 4A9(18)
  52. 4E1.2(9)
  53. 4LO3311(18)
  54. 50-6(5)
  55. 500A2(20)
  56. 509F6(8)
  57. 51(9)
  58. 53-5.8(19)
  59. 53-6.7(19)
  60. 55R-170(15)
  61. 55R-593(15)
  62. 5C8(3)
  63. 5G11(11)
  64. 6B11(5)
  65. 7B10(15)
  66. 7E.17G9(19)
  67. 7G7B6(19)
  68. 8C8(9)
  69. 9(5)
  70. 9000000000(10)
  71. 927(18)
  72. 9a2(9)
  73. 9D9(19)
  74. 9E9(8)
  75. 9H10(23)
  76. A4C8.1-Do9(10)
  77. A7R34(6)
  78. Abituzumab(3)
  79. Abrilumab(3)
  80. Aducanumab(3)
  81. AF6-88.5(9)
  82. Afasevikumab(3)
  83. AFS98(19)
  84. ALF-161(10)
  85. Amatuximab(3)
  86. Anifrolumab(3)
  87. Anrukinzumab(3)
  88. Apamistamab(3)
  89. Aprutumab(3)
  90. Atezolizumab(3)
  91. Atibuclimab(3)
  92. Avelumab(3)
  93. Avizakimab(3)
  94. B122(10)
  95. B22/249(14)
  96. B6H12(21)
  97. B7/21(5)
  98. B8-24-3(14)
  99. B8.2C12(5)
  100. Bamlanivimab(3)
  101. Bapineuzumab(3)
  102. Basiliximab(3)
  103. Batoclimab(3)
  104. Bavbio(5)
  105. Bavituximab(3)
  106. BC8(19)
  107. BE29G1(15)
  108. Begelomab(3)
  109. Belantamab(3)
  110. Belimumab(3)
  111. Bemarituzumab(3)
  112. Bermekimab(3)
  113. Bersanlimab(3)
  114. Bertilimumab(3)
  115. Bevacizumab(3)
  116. Bexmarilimab(3)
  117. Bimekizumab(3)
  118. Bivatuzumab(3)
  119. Bleselumab(3)
  120. Blosozumab(3)
  121. Bococizumab(3)
  122. Brazikumab(3)
  123. Brentuximab(3)
  124. Briakinumab(3)
  125. Brodalumab(3)
  126. Burosumab(3)
  127. BVD6-24G2(4)
  128. C1.18.4(11)
  129. C17.8(7)
  130. C71/16(16)
  131. C9B7W(18)
  132. Cadbio(5)
  133. Camidanlumab(3)
  134. Camrelizumab(3)
  135. Canakinumab(3)
  136. Caplacizumab(7)
  137. Carlumab(3)
  138. CD28.2(7)
  139. Cedelizumab(3)
  140. Cemiplimab(3)
  141. Cendakimab(3)
  142. Cetuximab(3)
  143. CHK-166(10)
  144. CHK152(5)
  145. Cibbio(5)
  146. Cixutumumab(3)
  147. Clazakizumab(3)
  148. Clenoliximab(3)
  149. Clervonafusp Alfa(4)
  150. Clesrovimab(3)
  151. Codrituzumab(3)
  152. Coltuximab(3)
  153. Cusatuzumab(3)
  154. CXCR3-173(18)
  155. Cy34.1(22)
  156. D12(4)
  157. D5(10)
  158. Dacetuzumab(3)
  159. Daclizumab(3)
  160. Daratumumab(3)
  161. DATK32(15)
  162. Daxdilimab(3)
  163. DC101(14)
  164. Dectrekumab(3)
  165. Denintuzumab(3)
  166. Denosumab(3)
  167. DREG56(5)
  168. Dupilumab(3)
  169. Durvalumab(3)
  170. Dusigitumab(3)
  171. E18(10)
  172. Edrecolomab(3)
  173. Efalizumab(3)
  174. EGFR.1(14)
  175. Eldelumab(3)
  176. Elipovimab(3)
  177. Elotuzumab(3)
  178. Emapalumab(3)
  179. Emibetuzumab(3)
  180. Enfortumab(3)
  181. Enibarcimab(3)
  182. Enoblituzumab(3)
  183. Enokizumab(3)
  184. Epratuzumab(5)
  185. Eptinezumab(3)
  186. Erenumab(3)
  187. ERIC-1(11)
  188. Erlizumab(3)
  189. Etaracizumab(3)
  190. Etokimab(3)
  191. Etrolizumab(3)
  192. Evinacumab(3)
  193. Evolocumab(3)
  194. Faralimomab(3)
  195. Farletuzumab(3)
  196. Fasinumab(3)
  197. FD441.8(15)
  198. Felzartamab(3)
  199. Fezakinumab(3)
  200. FGK4.5(19)
  201. FIB21(9)
  202. FIB27(3)
  203. FIB504(24)
  204. Ficlatuzumab(3)
  205. Figitumumab(3)
  206. Fletikumab(3)
  207. Fontolizumab(3)
  208. Foralumab(3)
  209. FR70(11)
  210. Fremanezumab(3)
  211. Fresolimumab(3)
  212. Frunevetmab(3)
  213. Fulranumab(3)
  214. G11(5)
  215. G28.5(19)
  216. G8.8(14)
  217. Galcanezumab(3)
  218. Gantenerumab(3)
  219. Gatralimab(3)
  220. Gemtuzumab(3)
  221. Gevokizumab(3)
  222. Giloralimab(3)
  223. Gimsilumab(3)
  224. GIR 208(9)
  225. Girentuximab(3)
  226. GK1.5(19)
  227. GL1(14)
  228. GL113(3)
  229. Glembatumumab(3)
  230. Grebio(5)
  231. Guselkumab(3)
  232. H22(20)
  233. H57-597(14)
  234. HB-14(7)
  235. HDB-4A7(9)
  236. HEK/1/85a/7a(18)
  237. HK1.4(10)
  238. HK2.1(15)
  239. HK5.3(15)
  240. HKSP(10)
  241. HKSP84(10)
  242. HM48-1(17)
  243. I21/7(15)
  244. I3/2.3(10)
  245. Ibalizumab(3)
  246. ICRF44(5)
  247. Ieramilimab(3)
  248. Ifibio(5)
  249. Ifinatamab(3)
  250. IK22/5(9)
  251. IM7(19)
  252. Indusatumab(3)
  253. Infliximab(3)
  254. Inolimomab(3)
  255. Intetumumab(3)
  256. Ipilimumab(3)
  257. Iratumumab(3)
  258. Isatuximab(3)
  259. Iscalimab(3)
  260. Itepekimab(3)
  261. Itolizumab(3)
  262. Ivuxolimab(3)
  263. Ixekizumab(3)
  264. J43(4)
  265. JAMA-147(10)
  266. JES5-2A5(4)
  267. JES6-1A12(5)
  268. JES6-5H4(4)
  269. Keliximab(3)
  270. L243(10)
  271. Lacnotuzumab(3)
  272. Lebrikizumab(3)
  273. Lemzoparlimab(3)
  274. Lenzilumab(3)
  275. Lerdelimumab(3)
  276. Lintuzumab(3)
  277. LO-CD2a(4)
  278. Lucatumumab(3)
  279. Lulizumab(3)
  280. Lumiliximab(3)
  281. Lusvertikimab(3)
  282. M1/69(8)
  283. M1/70(15)
  284. M290(4)
  285. M5/114.15.2(18)
  286. M5/49.4.1(10)
  287. Magrolimab(3)
  288. MAR 18.5(18)
  289. MAR1-5A3(19)
  290. Margetuximab(3)
  291. Matuzumab(3)
  292. Mavrilimumab(3)
  293. MB22-11(14)
  294. MD5-1(15)
  295. MECA-367(14)
  296. MECA-89(10)
  297. MEL-14(15)
  298. Metelimumab(3)
  299. Mezagitamab(3)
  300. MFL3(18)
  301. MIB-5E9.1(5)
  302. MIG-2F5-5(18)
  303. Minretumomab(3)
  304. Mirikizumab(3)
  305. Mirvetuximab(3)
  306. Mitazalimab(3)
  307. MJ18(18)
  308. MJ7/18(8)
  309. Monalizumab(3)
  310. Motavizumab(3)
  311. MP1-22E9(19)
  312. MP4-25D2(7)
  313. MP5-20F3(4)
  314. MPC-11(10)
  315. MR1(4)
  316. Mupadolimab(3)
  317. Muromonab(3)
  318. N418(5)
  319. Nadunolimab(3)
  320. Namilumab(3)
  321. Naratuximab(3)
  322. Natalizumab(3)
  323. Naxitamab(3)
  324. Necitumumab(3)
  325. Nemolizumab(3)
  326. Nerelimomab(3)
  327. Nesvacumab(3)
  328. Netakimab(3)
  329. Nipocalimab(3)
  330. Nivolumab(3)
  331. Obexelimab(3)
  332. Ocaratuzumab(3)
  333. Odulimomab(3)
  334. Ofatumumab(3)
  335. OKT-4(19)
  336. OKT10(19)
  337. Oleclumab(3)
  338. Olokizumab(3)
  339. Omalizumab(3)
  340. Omburtamab(3)
  341. Onvatilimab(3)
  342. Otelixizumab(3)
  343. Otilimab(3)
  344. OX-26(18)
  345. OX-7(18)
  346. OX-86(19)
  347. OX-90(18)
  348. Ozanezumab(3)
  349. Ozuriftamab(3)
  350. P84(9)
  351. Palivizumab(3)
  352. Pamrevlumab(3)
  353. Panitumumab(3)
  354. Parsatuzumab(3)
  355. Pascolizumab(3)
  356. Patbio(5)
  357. Pateclizumab(3)
  358. Patritumab(3)
  359. PC61(14)
  360. Pembrolizumab(3)
  361. Penpulimab(3)
  362. Perakizumab(3)
  363. Pertuzumab(3)
  364. Pinatuzumab(3)
  365. Pivekimab(3)
  366. PK136(19)
  367. Polatuzumab(3)
  368. Ponezumab(3)
  369. Ponsegromab(3)
  370. PS/2(18)
  371. Quetmolimab(3)
  372. R1-2(3)
  373. R4-6A2(12)
  374. RA3-6B2(19)
  375. Ramucirumab(3)
  376. Ravagalimab(3)
  377. RB6-8C5(19)
  378. Relatlimab(3)
  379. RG9-1(18)
  380. Rilotumumab(3)
  381. Ripertamab(3)
  382. Rituximab(5)
  383. RM134L(14)
  384. RM27-3E5(23)
  385. RMP1-14(26)
  386. RMP1-14-mAbMods(5)
  387. RMP1-14-mAbMods (D265A)(5)
  388. RMP1-14-mAbMods (LALA-PG)(5)
  389. RMP1-30(6)
  390. RMT1-10(14)
  391. RMT3-23(10)
  392. RMT4-53(10)
  393. Robatumumab(3)
  394. Rolinsatamab(3)
  395. Romosozumab(3)
  396. Rontalizumab(3)
  397. Rosopatamab(3)
  398. Rovalpituzumab(3)
  399. Rozanolixizumab(3)
  400. Sabatolimab(3)
  401. Sacituzumab(3)
  402. Sarilumab(3)
  403. Satralizumab(3)
  404. Secukinumab(3)
  405. Selicrelumab(3)
  406. Sifalimumab(3)
  407. Siltuximab(3)
  408. Simtuzumab(3)
  409. Sintilimab(3)
  410. Siplizumab(3)
  411. Sirukumab(3)
  412. SJ25-C1(6)
  413. Sofituzumab(3)
  414. Sotigalimab(3)
  415. Spesolimab(3)
  416. Sutimlimab(3)
  417. Suvizumab(3)
  418. T24/31(19)
  419. T29/33(5)
  420. T3-3A1(5)
  421. T56/14(5)
  422. TA-99(10)
  423. Tabalumab(3)
  424. Tadocizumab(3)
  425. Tafasitamab(3)
  426. Talbio(5)
  427. TAN1-7(19)
  428. Tanezumab(3)
  429. Tecbio(5)
  430. Teneliximab(3)
  431. Teplizumab(3)
  432. Teprotumumab(3)
  433. Tezepelumab(3)
  434. TIF-3C5(9)
  435. Tilavonemab(3)
  436. Tilvestamab(3)
  437. Tinurilimab(3)
  438. Tiragolumab(3)
  439. Tislelizumab(3)
  440. TKS-1(18)
  441. TN3-19.12(19)
  442. Tocilizumab(3)
  443. Toripalimab(3)
  444. Tositumomab(3)
  445. Tovetumab(3)
  446. TR75-54.7(15)
  447. Tralokinumab(3)
  448. Trastuzumab(3)
  449. Tregalizumab(3)
  450. TRFK5(14)
  451. Tusamitamab(3)
  452. TY/23(25)
  453. TY25(9)
  454. Ublituximab(3)
  455. UC10-4F10-11(19)
  456. UC3-10A6(15)
  457. UC7-13D5(10)
  458. UCHL-1(5)
  459. UCHM-1(5)
  460. UCHT-1(10)
  461. UCHT-2(5)
  462. UCHT-4(5)
  463. Uliledlimab(3)
  464. Upifitamab(3)
  465. Urabrelimab(3)
  466. Urelumab(3)
  467. Ustekinumab(3)
  468. Utomilumab(3)
  469. Vadastuximab(3)
  470. Vanalimab(3)
  471. Varisacumab(3)
  472. Varlilumab(3)
  473. Vatelizumab(3)
  474. Vedolizumab(3)
  475. Veltuzumab(3)
  476. Vibostolimab(3)
  477. Visilizumab(3)
  478. VL-4(10)
  479. Volociximab(3)
  480. Vunakizumab(3)
  481. W6/32(15)
  482. Xentuzumab(3)
  483. XMG1.2(19)
  484. Y-3(15)
  485. Y-3P(10)
  486. YN1/1.7.4(19)
  487. YTS-169(19)
  488. YTS191(18)
  489. Zagotenemab(3)
  490. Zalutumumab(3)
  491. Zanolimumab(3)
  492. Zilovertamab(3)
  493. Ziltivekimab(3)
  494. Zinlirvimab(3)
  495. Zolbetuximab(3)
  496. Zolimomab(3)
  497. ZV67(5)
Applications
Isotype
Hersteller

In Vivo Antibodies

13369 Artikel

pro Seite

Seite:
  1. 62
  2. 63
  3. 64
  4. 65
  5. 66
Name PDF Typ Clone Specific against Appl. Host ArtNr. Menge ✓ Preis
Anti-­Human CD3xCEACAM5 (Cibisatamab) Sicherheitsdatenblatt downloaden Biosimilars Cibbio Hu CHO cells B22117301-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human CD3xCEACAM5 (Cibisatamab) Sicherheitsdatenblatt downloaden Biosimilars Cibbio Hu CHO cells B22117301-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human CD3xCEACAM5 (Cibisatamab) Sicherheitsdatenblatt downloaden Biosimilars Cibbio Hu CHO cells B22117301-100mg

Biointron 		100 mg Anmelden
Vergleichen
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Sicherheitsdatenblatt downloaden Biosimilars Cadbio Hu CHO cells B22169601-1mg

Biointron 		1 mg Anmelden
Vergleichen
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Sicherheitsdatenblatt downloaden Biosimilars Cadbio Hu CHO cells B22169601-5mg

Biointron 		5 mg Anmelden
Vergleichen
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Sicherheitsdatenblatt downloaden Biosimilars Cadbio Hu CHO cells B22169601-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Sicherheitsdatenblatt downloaden Biosimilars Cadbio Hu CHO cells B22169601-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Sicherheitsdatenblatt downloaden Biosimilars Cadbio Hu CHO cells B22169601-100mg

Biointron 		100 mg Anmelden
Vergleichen
Anti-­Human CD3xBCMA (Teclistamab) Sicherheitsdatenblatt downloaden Biosimilars Tecbio Hu CHO cells B22224101-1mg

Biointron 		1 mg Anmelden
Vergleichen
Anti-­Human CD3xBCMA (Teclistamab) Sicherheitsdatenblatt downloaden Biosimilars Tecbio Hu CHO cells B22224101-5mg

Biointron 		5 mg Anmelden
Vergleichen
Anti-­Human CD3xBCMA (Teclistamab) Sicherheitsdatenblatt downloaden Biosimilars Tecbio Hu CHO cells B22224101-25mg

Biointron 		25 mg Anmelden
Vergleichen
Anti-­Human CD3xBCMA (Teclistamab) Sicherheitsdatenblatt downloaden Biosimilars Tecbio Hu CHO cells B22224101-50mg

Biointron 		50 mg Anmelden
Vergleichen
Anti-­Human CD3xBCMA (Teclistamab) Sicherheitsdatenblatt downloaden Biosimilars Tecbio Hu CHO cells B22224101-100mg

Biointron 		100 mg Anmelden
Vergleichen
Adalimumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-adalimumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Alemtuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-alemtuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Bevacizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-bevacizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Cetuximab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-cetuximab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Eculizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-eculizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Infliximab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-infliximab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Matuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-matuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Nimotuzumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-nimotuzumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Nivolumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-nivolumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Omalizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-omalizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Rituximab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-rituximab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Tocilizumab Biosimilar -­ Research Grade Biosimilars Hu AFIM-ab-131-tocilizumab

AffinityImmuno 		500 ug Anmelden
Vergleichen
Name Preis
Anti-­Human CD3xCEACAM5 (Cibisatamab) Anmelden Anti-Human CD3xCEACAM5 (Cibisatamab)
Typ Biosimilars
Clone Cibbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human CD3xCEACAM5 (Cibisatamab) Anmelden Anti-Human CD3xCEACAM5 (Cibisatamab)
Typ Biosimilars
Clone Cibbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human CD3xCEACAM5 (Cibisatamab) Anmelden Anti-Human CD3xCEACAM5 (Cibisatamab)
Typ Biosimilars
Clone Cibbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Anmelden Anti-Human PD-1xCTLA-4 (Cadonilimab)
Typ Biosimilars
Clone Cadbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Anmelden Anti-Human PD-1xCTLA-4 (Cadonilimab)
Typ Biosimilars
Clone Cadbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Anmelden Anti-Human PD-1xCTLA-4 (Cadonilimab)
Typ Biosimilars
Clone Cadbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Anmelden Anti-Human PD-1xCTLA-4 (Cadonilimab)
Typ Biosimilars
Clone Cadbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human PD-­1xCTLA-­4 (Cadonilimab) Anmelden Anti-Human PD-1xCTLA-4 (Cadonilimab)
Typ Biosimilars
Clone Cadbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Anti-­Human CD3xBCMA (Teclistamab) Anmelden Anti-Human CD3xBCMA (Teclistamab)
Typ Biosimilars
Clone Tecbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 1 mg
Lieferbar
Anti-­Human CD3xBCMA (Teclistamab) Anmelden Anti-Human CD3xBCMA (Teclistamab)
Typ Biosimilars
Clone Tecbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 5 mg
Lieferbar
Anti-­Human CD3xBCMA (Teclistamab) Anmelden Anti-Human CD3xBCMA (Teclistamab)
Typ Biosimilars
Clone Tecbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 25 mg
Lieferbar
Anti-­Human CD3xBCMA (Teclistamab) Anmelden Anti-Human CD3xBCMA (Teclistamab)
Typ Biosimilars
Clone Tecbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 50 mg
Lieferbar
Anti-­Human CD3xBCMA (Teclistamab) Anmelden Anti-Human CD3xBCMA (Teclistamab)
Typ Biosimilars
Clone Tecbio
Specific against Hu
Appl.
Host CHO cells
ArtNr.
Menge 100 mg
Lieferbar
Adalimumab Biosimilar -­ Research Grade Anmelden Adalimumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Alemtuzumab Biosimilar -­ Research Grade Anmelden Alemtuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Bevacizumab Biosimilar -­ Research Grade Anmelden Bevacizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Cetuximab Biosimilar -­ Research Grade Anmelden Cetuximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Eculizumab Biosimilar -­ Research Grade Anmelden Eculizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Infliximab Biosimilar -­ Research Grade Anmelden Infliximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Matuzumab Biosimilar -­ Research Grade Anmelden Matuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Nimotuzumab Biosimilar -­ Research Grade Anmelden Nimotuzumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Nivolumab Biosimilar -­ Research Grade Anmelden Nivolumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Omalizumab Biosimilar -­ Research Grade Anmelden Omalizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Rituximab Biosimilar -­ Research Grade Anmelden Rituximab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar
Tocilizumab Biosimilar -­ Research Grade Anmelden Tocilizumab Biosimilar - Research Grade
Typ Biosimilars
Clone
Specific against Hu
Appl.
Host
ArtNr.
Menge 500 ug
Lieferbar

13369 Artikel

pro Seite

Seite:
  1. 62
  2. 63
  3. 64
  4. 65
  5. 66
Kontakt

Hölzel Diagnostika Handels GmbH
Weinsbergstr 118a
D-50823 Köln

T +49 221 126 02 66
F +49 221 126 02 67

info@hoelzel.de

Über Hölzel
Service
Infothek
Spendenaktion Datenschutzsiegel

Copyright 2025 Hölzel Diagnostika Handels GmbH

To top